Multiple	O
enhancer	O
regions	O
govern	O
the	O
transcription	O
of	O
CCN2	O
during	O
embryonic	O
development	O
.	O


CCN2	O
is	O
a	O
critical	O
matricellular	O
protein	O
that	O
is	O
expressed	O
in	O
several	O
cells	O
with	O
major	O
implications	O
in	O
physiology	O
and	O
different	O
pathologies	O
.	O


However	O
,	O
the	O
transcriptional	O
regulation	O
of	O
this	O
gene	O
remains	O
obscure	O
.	O


We	O
used	O
the	O
Encyclopaedia	O
of	O
DNA	O
Elements	O
browser	O
(	O
ENCODE	O
)	O
to	O
visualise	O
the	O
region	O
spanning	O
from	O
300	O
kb	O
upstream	O
to	O
the	O
CCN2	O
start	O
site	O
in	O
silico	O
in	O
order	O
to	O
identify	O
enhancer	O
regions	O
that	O
regulate	O
transcription	O
of	O
this	O
gene	O
.	O


Selection	O
was	O
based	O
on	O
three	O
criteria	O
associated	O
with	O
enhancer	O
regions	O
:	O
1	O
)	O
H3K4me1	O
and	O
H3K27ac	O
histone	O
modifications	O
,	O
2	O
)	O
DNase	O
I	O
hypersensitivity	O
of	O
chromatin	O
and	O
3	O
)	O
inter	O
-	O
species	O
conservation	O
.	O


Reporter	O
constructs	O
were	O
created	O
with	O
sequences	O
spanning	O
each	O
of	O
the	O
regions	O
of	O
interest	O
placed	O
upstream	O
of	O
an	O
Hsp68	O
silent	O
proximal	O
promoter	O
sequence	O
in	O
order	O
to	O
drive	O
the	O
expression	O
of	O
beta	O
-	O
galactosidase	O
transgene	O
.	O


Each	O
of	O
these	O
constructs	O
was	O
subsequently	O
used	O
to	O
create	O
transgenic	O
mice	O
in	O
which	O
reporter	O
gene	O
production	O
was	O
assessed	O
at	O
the	O
E15	O
.	O
5	O
developmental	O
stage	O
.	O


Four	O
functional	O
enhancers	O
were	O
identified	O
,	O
with	O
each	O
driving	O
distinct	O
,	O
tissue	O
-	O
specific	O
patterns	O
of	O
transgene	O
expression	O
.	O


An	O
enhancer	O
located	O
-	O
100	O
kb	O
from	O
the	O
CCN2	O
transcription	O
start	O
site	O
facilitated	O
expression	O
within	O
vascular	O
tissue	O
.	O


An	O
enhancer	O
-	O
135	O
kb	O
upstream	O
of	O
CCN2	O
drove	O
expression	O
within	O
the	O
articular	O
chondrocytes	O
of	O
synovial	O
joints	O
.	O


The	O
other	O
two	O
enhancers	O
,	O
located	O
at	O
-	O
198	O
kb	O
and	O
-	O
229	O
kb	O
,	O
mediated	O
transgene	O
expression	O
within	O
dermal	O
fibroblasts	O
,	O
however	O
the	O
most	O
prevalent	O
activity	O
was	O
found	O
within	O
hypertrophic	O
chondrocytes	O
and	O
periosteal	O
tissue	O
,	O
respectively	O
.	O


These	O
findings	O
suggest	O
that	O
the	O
global	O
expression	O
of	O
CCN2	O
during	O
development	O
results	O
from	O
the	O
activity	O
of	O
several	O
tissue	O
-	O
specific	O
enhancer	O
regions	O
in	O
addition	O
to	O
proximal	O
regulatory	O
elements	O
that	O
have	O
previously	O
been	O
demonstrated	O
to	O
drive	O
transcription	O
of	O
the	O
gene	O
during	O
development	O
.	O
